Prospective Grant of Exclusive Patent License - 19-011-EX1

U.S. DEPARTMENT OF COMMERCE

National Institute of Standards and Technology

Prospective Grant of Exclusive Patent License

AGENCY: National Institute of Standards and Technology, Department of Commerce

ACTION: Notice; prospective grant of exclusive patent license.

SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that the National Institute of Standards and Technology (“NIST”), U.S. Department of Commerce, intends to grant to Cognitive Security Institute, of Redmond, Oregon an exclusive license in the United States of America, its territories, possessions and commonwealths, to NIST's interest in the invention embodied in the following patents:

US Patent Number: 10,975,369

Title: DI-ENZYMATIC CHIMERIC ENDOLYSIN

Application Filing Date: 10/31/2019

The grant of the license would be for development and sale of products and services in the area of industrial and agriculture.

FOR FURTHER INFORMATION, CONTACT: Cecile Pham, Patenting and Licensing Manager, btp@nist.gov.

SUPPLEMENTARY INFORMATION: The prospective exclusive license will be royalty bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within fifteen (15) days from the date of this published Notice, NIST receives written evidence and argument which establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.

Dates: Only written comments or applications for a license (or both) which are received by the NIST Technology Partnerships Office on or before March 28, 2025, will be considered.

Bethany Loftin,

Director, Technology Partnerships Office